Making medical cannabis accessible
Panaxia (panaxia.co.il) scores 72 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Manufacturing brands, in the 29th percentile of 14661 Healthcare brands.
Panaxia is an Israeli pharmaceutical company founded in 2010 and headquartered in Lod, specializing in medical cannabis products. The company applies pharmaceutical-grade research and development to create standardized, reliable dosage forms and delivery systems for cannabis-based medicines. Panaxia aims to make medical cannabis accessible and usable in the same manner as conventional pharmaceuticals, serving patients, healthcare providers, pharmacies, and pharmaceutical partners. The company is led by CEO Dadi Segal and operates within the healthcare and manufacturing sectors.
| Brand Name | Panaxia |
|---|---|
| Domain | panaxia.co.il |
| Industry | Healthcare, Manufacturing |
| Founded | 2010 |
| Headquarters | Lod |
| CEO | Dadi Segal |
| Main Competitors | Tikun Olam, InterCure (Canndoc), Together Pharma (60/100), BOL Pharma, Tilray (81/100), Canopy Growth (86/100), GW Pharmaceuticals (74/100) |
Moz Domain Authority 29/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Panaxia has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "We go beyond making medical cannabis products. We make them accessible. Panaxia is transforming pharmaceutical cannabis with consistent, effective, high-quality products that can b…" (No meta description. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Panaxia?", Claude could identify the brand as of October 2026. Panaxia is an Israeli company specializing in the production of medical cannabis and pharmaceutical-grade cannabis products, including standardized pills, capsules, and inhalers. It operates GMP-certified manufacturing facilities and is one of the more established players in Isra Best known for Producing standardized, pharmaceutical-grade medical cannabis products in Israel.
When asked "Best brands similar to Panaxia?", Claude would recommend Panaxia as of October 2026. It's a recognized name in the Israeli medical cannabis sector, so it would come up naturally if discussing cannabis-based healthcare companies in that market.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Panaxia's main competitors in Healthcare: Together Pharma (60/100), Tilray (81/100), Canopy Growth (86/100), GW Pharmaceuticals (74/100).
Sources: Brand Analyzer scan
Panaxia is an Israeli pharmaceutical company, founded in 2010 and based in Lod, that specializes in the research, development, and manufacturing of medical cannabis products. It operates within the healthcare and manufacturing sectors, focusing on creating standardized, pharmaceutical-grade cannabis-based medicines.
Sources: Panaxia official site
Panaxia has moderate AI-search visibility, scoring 51/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 33, recommendation 52). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Panaxia official site
Panaxia was founded in 2010. Panaxia operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Panaxia is headquartered in Lod. Panaxia operates in the Healthcare category.
Sources: Wikidata
Panaxia develops and manufactures a broad range of medical cannabis dosage forms and delivery systems. Using pharmaceutical-grade R&D and manufacturing processes, the company creates consistent, standardized cannabis-based products designed to be used similarly to conventional medicines, serving patients, healthcare providers, and pharmacies.
Sources: Panaxia official site
Panaxia scores 52/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Panaxia official site
Panaxia can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Panaxia official site
Panaxia offers a broad range of medical cannabis dosage forms and delivery systems, developed through its R&D capabilities to meet varying patient needs. These pharmaceutical-grade products are designed to be used in a manner consistent with other standardized medicines.
Sources: Panaxia official site
Panaxia's products and services are used by patients requiring medical cannabis treatments, as well as healthcare providers, pharmacies, and pharmaceutical partners seeking standardized and reliable cannabis-based medicines.
Sources: Panaxia official site
Panaxia is known for transforming pharmaceutical cannabis into standardized, consistent, and pharmaceutical-grade products. The company is recognized for applying rigorous scientific and quality-control standards to medical cannabis manufacturing, bridging traditional pharmaceutical practices with cannabis-based treatments.
Sources: Panaxia official site
Panaxia scores 51/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Panaxia has a limited AI-visibility profile at 51/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (33/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 29/100, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Panaxia from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Panaxia: Oxide AI (72/100), Ovation (72/100), Paperboat (72/100), ParcelShield (72/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.